Icon

VENLAFAXINE HYDROCHLORIDE (nda022104)- (EQ 37.5MG BASE,EQ 75MG BASE,EQ 150MG BASE,EQ 225MG BASE)

VENLAFAXINE HYDROCHLORIDE OSMOTICA PHARM US
EQ 37.5MG BASE,EQ 75MG BASE,EQ 150MG BASE,EQ 225MG BASE
Yes Yes
2017-Mar-20 Expired
None None
None No
Venlafaxine Extended Release Tablets are a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: • Major Depressive Disorder (MDD) • Social Anxiety Disorder (SAD)
12 0 11
Total Other Developers 26
Drugs with Suitability No
EQ 37.5MG BASE ** ** - - 6
EQ 75MG BASE ** ** - 6 2
EQ 150MG BASE ** ** - 8 2
EQ 225MG BASE ** ** - - 10
NDA Sales Available Total Generic Sales Available
No 11
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ****** * * ********* *** *************** ******* *********** **** **. ***-***, *.*.*.* ********** ****, *******, ******, ***** (***) ***
****** ****** ****** *** ****** ****** ******* *********** **** **. *-*** /* ***** *** - **** **, *******, ******* ******, ***** (***) ***
****** ****** ****** *** ****** *************** ******* *********** ****, ****** ****, ******, *********, ******* ******, ***** (***) ***
****** ****** ****** ****** ************ - ******* ******* *********** ** *******, ***** *******, *******, ****** (***) ***
****** ****** ****** ***. *********** * ******, ** *****, *******, ****** (***) ***
****** ******* **** *** ******* ************, ***. *********** **** * ******* ******, ****** ****, ******** (**) *****, ****** ****** (***) ***
****** ****** ****** ****** ************ - ******* ******* *********** ** *******, ***** *******, *******, ****** (***) ***
****** ***** ***** ****** *** *********** *** *** *** ********* ** ***** *, *, *-* & *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** ***** **. *****'* ************ *********, *** *********** **** **** ******, **********, ********* (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.